These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7598490)

  • 21. Transgenic animal mutation models: a review of the models and how they function.
    Dean S
    Methods Mol Biol; 2012; 817():377-97. PubMed ID: 22147581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of transgenic mutational test systems in risk assessment of carcinogens.
    Schmezer P; Eckert C; Liegibel UM; Klein RG; Bartsch H
    Arch Toxicol Suppl; 1998; 20():321-30. PubMed ID: 9442305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LacZ transgenic mouse models: their application in genetic toxicology.
    Gossen JA; de Leeuw WJ; Vijg J
    Mutat Res; 1994 Jun; 307(2):451-9. PubMed ID: 7514719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of O (6)-alkylguanine-DNA alkyltransferase deficiency in Escherichia coli as the host for the detection of mutations in lacI transgenic mice.
    Sui H; Suzuki M; Yamada M; Hara T; Kawakami K; Shibuya T; Nohmi T; Sofuni T
    Environ Mol Mutagen; 1999; 34(2-3):221-6. PubMed ID: 10529748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High resolution mapping of UV-induced photoproducts in the Escherichia coli lacI gene. Inefficient repair of the non-transcribed strand correlates with high mutation frequency.
    Chandrasekhar D; Van Houten B
    J Mol Biol; 1994 May; 238(3):319-32. PubMed ID: 8176728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational spectra of tamoxifen-induced mutations in the livers of lacI transgenic rats.
    Davies R; Oreffo VI; Bayliss S; Dinh PA; Lilley KS; White IN; Smith LL; Styles JA
    Environ Mol Mutagen; 1996; 28(4):430-3. PubMed ID: 8991074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three origins of phiX174 am3 revertants in transgenic cell culture.
    Malling HV; Delongchamp RR; Valentine CR
    Environ Mol Mutagen; 2003; 42(4):258-73. PubMed ID: 14673871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel Escherichia coli-derived mutation detected with the Big Blue cII mutant selectable assay.
    Ward TL; Prtenjaca A; Hill KA
    Environ Mol Mutagen; 2010 May; 51(4):344-8. PubMed ID: 20120017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.
    Recio L; Bond JA; Pluta LJ; Sisk SC
    IARC Sci Publ; 1993; (127):235-43. PubMed ID: 8070869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage lambda and plasmid pUR288 transgenic fish models for detecting in vivo mutations.
    Winn RN; Norris M; Muller S; Torres C; Brayer K
    Mar Biotechnol (NY); 2001 Jun; 3(Supplement 1):S185-95. PubMed ID: 14961315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel germline mutation in Big Blue mice.
    Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA
    Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
    Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
    Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying in vivo somatic mutations using transgenic mouse model systems.
    Swiger RR
    Methods Mol Biol; 2005; 291():145-53. PubMed ID: 15502219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of Muta™Mouse λgt10-lacZ transgene: evidence for in vivo rearrangements.
    Shwed PS; Crosthwait J; Douglas GR; Seligy VL
    Mutagenesis; 2010 Nov; 25(6):609-16. PubMed ID: 20724577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical analysis of lacZ mutant frequency data from MutaMouse mutagenicity assays.
    Fung KY; Douglas GR; Krewski D
    Mutagenesis; 1998 May; 13(3):249-55. PubMed ID: 9643583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay?
    Gunz D; Shephard SE; Lutz WK
    Environ Mol Mutagen; 1993; 21(3):209-11. PubMed ID: 8462524
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study.
    Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J
    Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A perspective on measurement of mutations in vivo.
    Tennant RW
    Environ Mol Mutagen; 1991; 18(4):322-3. PubMed ID: 1748097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the protocols of transgenic mouse mutation assays.
    Nohmi T; Suzuki T; Masumura K
    Mutat Res; 2000 Nov; 455(1-2):191-215. PubMed ID: 11113476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.